600 related articles for article (PubMed ID: 6611141)
1. An introduction to tumour immunology.
James K
Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
[TBL] [Abstract][Full Text] [Related]
2. An introduction to tumour immunology.
Keith J
Mater Med Pol; 1984; 16(1):54-64. PubMed ID: 6394909
[No Abstract] [Full Text] [Related]
3. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
Jäger E; Jäger D; Knuth A
Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
[No Abstract] [Full Text] [Related]
4. Effector immune mechanisms in cancer.
Lotzová E
Nat Immun Cell Growth Regul; 1985; 4(6):293-304. PubMed ID: 3911064
[No Abstract] [Full Text] [Related]
5. [Natural killers and macrophages: their activity in leukemias].
Fi FT
Eksp Med Morfol; 1985; 24(2):63-70. PubMed ID: 3933945
[No Abstract] [Full Text] [Related]
6. Immune response to tumour antigens.
McConnell I
Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):381-4. PubMed ID: 347640
[TBL] [Abstract][Full Text] [Related]
7. Tumour immunotherapy: the adjuvant treatment of the 21st century?
Bremers AJ; Kuppen PJ; Parmiani G
Eur J Surg Oncol; 2000 Jun; 26(4):418-24. PubMed ID: 10873365
[TBL] [Abstract][Full Text] [Related]
8. [Monoclonal antibodies: toward the comprehension of the cellular dynamics of the immune system].
Piris Pinilla MA; Rivas Manga C
Med Clin (Barc); 1984 Jun; 83(3):122-8. PubMed ID: 6237234
[No Abstract] [Full Text] [Related]
9. [Tumour immunology (author's transl)].
Sellin D
Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():341-9. PubMed ID: 88727
[TBL] [Abstract][Full Text] [Related]
10. The gordian knot of tumour immunology.
Amlot P
Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511
[No Abstract] [Full Text] [Related]
11. Novel costimulators in the immune gene therapy of cancer.
Galea-Lauri J; Farzaneh F; Gäken J
Cancer Gene Ther; 1996; 3(3):202-14. PubMed ID: 8725885
[TBL] [Abstract][Full Text] [Related]
12. Natural killer (NK) cells and their possible roles in resistance against disease.
Herberman RB
Clin Immunol Rev; 1981; 1(1):1-65. PubMed ID: 6219848
[No Abstract] [Full Text] [Related]
13. [Immunology and tumors. Effector cells].
Sebastiani M; Cosma AM; Ferri AM
Arch Sci Med (Torino); 1980; 137(2):277-88. PubMed ID: 6971636
[TBL] [Abstract][Full Text] [Related]
14. [NK cells--their role and importance in antitumor resistance].
Mircheva Zh
Eksp Med Morfol; 1984; 23(2):99-104. PubMed ID: 6205848
[No Abstract] [Full Text] [Related]
15. Regulatory T cells, tumour immunity and immunotherapy.
Zou W
Nat Rev Immunol; 2006 Apr; 6(4):295-307. PubMed ID: 16557261
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of immunity in cancer.
Baldwin RW
Pathobiol Annu; 1981; 11():155-75. PubMed ID: 6460216
[No Abstract] [Full Text] [Related]
17. [Cell therapy in solid tumors].
Ravaud A
Bull Cancer; 2001 Jan; 88(1):91-100. PubMed ID: 11182658
[No Abstract] [Full Text] [Related]
18. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
Jäger D; Jäger E; Bert F; Knuth A
Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
[No Abstract] [Full Text] [Related]
19. Natural killer and other effector cells.
Stutman O; Lattime EC
Symp Fundam Cancer Res; 1986; 38():221-58. PubMed ID: 3489260
[No Abstract] [Full Text] [Related]
20. [Use of monoclonal antibodies in the study of the lymphoid system. II. Classification and treatment of the leukemias].
Blanco Quirós A; Alvarez Guisasola J
An Esp Pediatr; 1982 Jul; 17(1):48-59. PubMed ID: 6982643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
